Cargando…
Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer
Ovarian cancer (OC) is a malignant tumor with high mortality in women. Although cancer patients initially respond to paclitaxel chemotherapy following surgery, most patients will relapse after 12–24 months and gradually die from chemotherapy resistance. In OC, cancer cells become resistant to paclit...
Autores principales: | Feng, Lanlan, Shen, Fangrong, Zhou, Jinhua, Li, Yan, Jiang, Rong, Chen, Youguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109003/ https://www.ncbi.nlm.nih.gov/pubmed/32190895 http://dx.doi.org/10.1042/BSR20192457 |
Ejemplares similares
-
MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10
por: Yang, Xiangling, et al.
Publicado: (2019) -
Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells
por: Weiner-Gorzel, Karolina, et al.
Publicado: (2015) -
Hsa_circ_0001445 works as a cancer suppressor via miR‐576‐5p/SFRP1 axis regulation in ovarian cancer
por: Wu, Yuhong, et al.
Publicado: (2022) -
Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2
por: Zhang, Fenghua, et al.
Publicado: (2020) -
Hypoxia‐responsive miR‐124 and miR‐144 reduce hypoxia‐induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1
por: Gu, Hao, et al.
Publicado: (2016)